User

Overweight and Obesity as Risk Factors of Breast Cancer in Premenopausal and Postmenopausal Women: Meta-Analysis

Shofia Nur Fadhila, Bhisma Murti, Vitri Widyaningsih

Abstract

Background: A woman has an increased risk of breast cancer due to increased exposure to the hormone estrogen during her life due to early menarche, late menopause, and/or the absence of childbearing. Epidemiological data show that menopausal status has a risk factor for breast cancer. The aim of this study was to investigate overweight and obesity as risk factors for pre­menopausal and postmenopausal breast cancer.

Subjects and Method: A systematic review and meta-analysis study was conducted by systema­tically reviewing articles published from 2010-2021 in the PubMed, Google Scholar, SpringerLink and Science Direct databases with the keywords overweight AND obesity AND "breast cancer" OR "breast carcinoma" AND "premenopausal women", overweight AND obesity AND "breast cancer" OR "breast carcinoma" AND "postmenopausal women". Inclusion criteria included articles in English, full text, using an observational study design, and displaying adjusted odds ratios. Articles were reviewed using PRISMA diagrams and analyzed using Revman 5.3.

Results: A meta-analysis of 10 articles concluded that overweight women were 1.35 times more likely to develop premenopausal breast cancer than women with a normal BMI (aOR= 1.35; 95% CI= 0.98 to 1.86; p= 0.070). A meta-analysis of 10 articles concluded that obese women were 1.27 times more likely to develop premenopausal breast cancer than women with normal BMI (aOR= 1.27; 95% CI= 0.95 to 1.69; p= 0.110). A meta-analysis of 9 articles concluded that overweight women had a 1.28 times risk of developing postmenopausal breast cancer compared with women with a normal BMI (aOR= 1.28; 95% CI= 1.00 to 1.63; p= 0.050). A meta-analysis of 11 articles concluded that obese women were 1.52 times more likely to develop postmenopausal breast cancer than women with normal BMI (aOR= 1.52; 95% CI= 1.17 to 1.98; p= 0.002).

Conclusion: Overweight and obesity increase the risk of pre-menopausal and postmenopausal breast cancer.

Keywords: overweight, obesity, breast cancer, premenopause, postmenopausal.

Correspondence:  Shofia Nur Fadhila. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: shofianf@student.uns.ac.id.

Journal of Maternal and Child Health (2021), 06(06): 678-689
https://doi.org/10.26911/thejmch.2021.06.06.06

 

 

Full Text:

PDF

References

Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E and Brunetti A (2012). Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms. Exp. Diabetes Res. 2012. doi: 10.1155/2012/789174.


CEBMa (2014). Critical Appraisal for Case Control Study. Amsterdam.


Brown KA and Simpson ER (2014). Obesity and breast cancer: The role of dysregulated estrogen metabolism. Obes. Breast Cancer Role Dysregulated Estrogen Metab. 1–56. doi: 10.1007-/978-1-4899-8002-1.


Friedenreich CM (2001). Review of anthropometric factors and breast cancer risk. Eur. J. Cancer Prev., 10(1): 15–32. doi: 10.1097/00008469-200102000-000-03.


Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM and Harvie MN (2014). Risk determination and prevention of breast cancer. Breast Cancer Res. 16(5): 1–19. doi: 10.1186/s1305801404462.


Irwin ML, Varma K, Alvarez-reeves M, Cadmus L, Wiley A, Chung GG, Dipietro L, Mayne ST, Yu H and Haven N (2010). NIH Public Access, (203): 1–16. doi: 10.1158/1055-9965.EPI-08-0531.Ran-domized.


Iyengar NM, Hudis CA and Dannenberg AJ (2013). Obesity and Inflammation: New Insights into Breast Cancer Development and Progression. Am. Soc. Clin. Oncol. Educ. B. 33: 46–51. doi: 10.1200/edbook_am.2013.33.46.


Kamińska M, Ciszewski T, Łopacka-Szatan K, Miotła P and Starosławska E (2015). Breast cancer risk factors. Prz. Menopauzalny, 14(3): 196–202. doi: 10.5114/pm.2015.54346.


Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, Du B, Brogi E, Crawford CB, Kopelovich L, Dannen-berg AJ and Subbaramaiah K (2011). Breast Tissue of Obese Women With Breast Cancer. Cancer Prev. Res. (Phila). 4(7): 1021–9. doi: 10.1158/1940-6207.CAPR-11-0110.Inflammation.


Nindrea R, Aryandono T, Lazuardi L and Dwiprahasto I (2019). Association of overweight and obesity with breast cancer during premenopausal period in Asia: A meta-analysis. Int. J. Prev. Med. 10(1): 192. doi: 10.4103/IJPVM.IJPVM_372_18.


Pacholczak R, Klimek-Piotrowska W and Kuszmiersz P (2016). Associations of anthropometric measures on breast cancer risk in pre and postmenopausal women a case-control study. J. Physiol. Anthropol. 35(1). doi: 10.1186/S40101-016-0090-X.


Park JW, Han K, Shin DW, Yeo Y, Chang JW, Yoo JE, Jeong SM, Lee SK, Ryu JM and Park YM (2021). Obesity and breast cancer risk for pre and postmenopausal women among over 6 million Korean women. Breast Cancer Res. Treat. 185(2): 495–506. doi: 10.1007/s10549-020-05952-4.


Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER and Slingerland JM (2017). Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA. Cancer J. Clin., 67(5): 378–397. doi: 10.3322/CAAC.21405.


Rashid FA, Alhashemi WKH, Al-Saffar AT, Salman EA and Najeeb DA (2020). Obesity and breast cancer risk in different menopausal status: A review. Biochem. Cell. Arch., 20(1): 1875–1878. doi: 10.35124/bca.2020.20.1.1875.


Rojas K and Stuckey A (2016). Breast Cancer Epidemiology and Risk Factors. Clin. Obstet. Gynecol.59(4): 651–672. doi: 10.1097/GRF.0000000000000239.


Rowland AS, Baird DD, Long S, Wegienka G, Harlow SD, Alavanja M and Sandler DP (2002). Influence of medical conditions and lifestyle factors on the menstrual cycle. Epidemiology, 13(6): 668–674. doi: 10.1097/00001648-200211000-00011.


Sarkissyan M, Wu Y and Vadgama J V. (2011). Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles. Cancer, 117(16): 3814–3823. doi: 10.1002/cncr.25956.


Siegel RL, Miller KD and Jemal A (2020). Cancer statistics, 2020. CA. Cancer J. Clin. 70(1): 7–30. doi: 10.3322/caac.21590.


Suzuki R, Orsini N, Saji S, Key TJ and Wolk A (2009). Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-A meta-analysis. Int. J. Cancer. 124(3): 698–712. doi: 10.1002/ijc.23943.


Taleban R, Sirous R, Sirous M, Razavi S, Taghvaei R, Sirous S, Khalighinejad F, Dehghani Firouzabadi A, Qobadi M, Dehghani Firouzabadi F, Moafi M, Zand K and Farajzadegan Z (2019). The Relationship between Anthropometric Indices and Breast Cancer in Central Iran. Nutr. Cancer, 71(8): 1276–1282. doi: 10.1080/01635581.2019.1604005.


Wada K, Nagata C, Tamakoshi A, Matsuo K, Oze I, Wakai K, Tsuji I, Sugawara Y, Mizoue T, Tanaka K, Iwasaki M, Inoue M, Tsugane S and Sasazuki S (2014). Body mass index and breast cancer risk in Japan: A pooled analysis of eight population-based cohort studies. Ann. Oncol. 25(2): 519–524. doi: 10.1093/ANNONC/MDT542.


Wang Xin, Li L, Gao J, Liu J, Guo M, Liu L, Wang W, Wang J, Xing Z, Yu Z and Wang Xiang (2016). The Association Between Body Size and Breast Cancer in Han Women in Northern and Eastern China. Oncologist, 21(11): 1362–1368. doi: 10.1634/THEONCOLOGIST.2016-0147.


World Health Organisation (2018). Latest global cancer data: Cancer burden rises to 18. 1 million new cases and 9. 6 million cancer deaths in 2018 Latest global cancer data: Int. Agency Res. Cancer, (September): 13–15.

Refbacks

  • There are currently no refbacks.